Charlottesville Envision Enterprise Grant
Charlottesville Envision Enterprise Grant
United Way Charlottesville
ABOUT THE GRANT
The Envision Enterprise Grant provides Greater Charlottesville small businesses with $10,000 grants to support growth and expansion. Administered by the United Way of Greater Charlottesville in partnership with the City of Charlottesville Office of Economic Development and the Albemarle County Office of Economic Development, the program is intended for small, financially stable, for-profit businesses owned by socially disadvantaged individuals in the City of Charlottesville or Albemarle County. Funds may be used for a range of growth-related expenses, including hiring additional employees, ordering supplies and inventory, and investing in marketing. To be eligible, businesses must be located and licensed in the City of Charlottesville or Albemarle County, have been in operation for at least two consecutive years, have no more than 25 employees, generate net income of less than $200,000, and serve as the sole source of employment income for an owner who works for the business full-time. Current and former United Way of Greater Charlottesville grant recipients or Prosper program participants that received funding within the past calendar year are not eligible.
Tracking grants is our job
Sign up for The Grant Brief to get our latest grants every Tuesday. One email, zero fluff.
NOTES
We haven't added commentary on this grant yet. In the meantime, the fundor's website (linkeded above) is the best source for application details and eligibility specifics.
Not the right grant for you?
Other Grants
SC Relentless Challenge Grant
SC Department of Commerce
The South Carolina Department of Commerce provides the Relentless Challenge (RC) Grant Program. This is a statewide competitive scheme that plans to award approximately $1,000,000 for the 2026 funding cycle. The RC grant funds projects that foster a sustainable innovation ecosystem and that focus on high growth/high impact entrepreneurship, talent development, access to capital, and university/industry collaborations. Matching funds are available up to a maximum of $75,000.
TVA Special Opportunities Grant
Tennessee Valley Authority
TVA is investing in underserved areas with the Special Opportunities County (SOC) Performance Grant. By investing in competitive economic development projects, we’re standing by our mission and making life better for the people who live and work in the seven-state Valley region. This program assists smaller economic development projects in communities with greater economic needs. Funding amounts are based on the project’s five-year economic impact and are paid directly to the company.
Alcohol Treatment, Pharmacotherapy, and Recovery Research
National Institutes of Health
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery.
Arkansas Workforce Development Grants
Arkansas OSD
The State of Arkansas makes strategic investments in the state’s workforce through OSD training grants. These grants support the Arkansas workforce by assisting businesses to provide cutting edge, customized employee training. These are reimbursement grants with flexible structures based on employer size and the type of training program. HEad to the grant website for additional details.
Early Immune System Development and Ontogeny
National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is tofurther elucidate the mechanisms of early immune development in utero, during the early post-natal period and during early childhood in neonates, infants, and children and adolescents with or without in-utero exposure to HIV or Anti-Retroviral Therapeutics (ART).This initiative aims to understand intricate mechanisms of immune cells at the maternal-fetal interface, T and B cell development and maturation in offspring, and local immune responses and the role of systemic immunity.